FDA probes suicide risk for those using epilepsy drugs

06/4/2008 | Wall Street Journal, The

After an analysis that indicates some epilepsy treatments may increase the risk of suicidal behavior, the Food and Drug Administration held a closed meeting Monday with drug manufacturers to discuss adding a warning label to such medications. Some drug officials said the research might be flawed because it combines findings about 11 available epilepsy drugs, which are not necessarily alike.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Executive Director
Capitol Region Education Council (CREC)
Hartford, CT
Senior ELL Technical Assistance and Curriculum Specialist (8270)
American Institute for Researcher
Chicago, IL
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL